Dynamics of prescribing and accessing medications for opioid use disorder: a community-based systems analysis

被引:1
|
作者
Herman, Tianna [1 ]
Hasgul, Zeynep [1 ]
Lim, Tse Yang [2 ]
Jalali, Mohammad S. [1 ]
Stringfellow, Erin J. [1 ]
机构
[1] Harvard Med Sch, MGH Inst Technol Assessment, Boston, MA 02115 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
关键词
Medications for opioid use disorder; community-based system dynamics; opioid use disorder; group model building; opioid epidemic; causal loop diagram; METHADONE;
D O I
10.1080/16066359.2024.2420087
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundAlthough medications for opioid use disorder (MOUD) are effective for treating opioid use disorder (OUD), persistent barriers still prevent patients from accessing this life-saving care. Policies to increase MOUD access have produced suboptimal results. This study presents a qualitative system dynamics model that elucidates the complexities of accessing and staying in MOUD treatment.MethodsWe utilized a community-based system dynamics approach to modeling the MOUD treatment system. We engaged a cohort of system experts/stakeholders, including individuals who had received MOUD, treatment providers, and policymakers, in interviews and group model building to develop and refine a simulation model. We then created a qualitative causal loop diagram based on insights gained while developing the simulation model and a review of interview transcripts.ResultsThe causal loop diagram captures four key factors affecting treatment initiation, retention, and leaving: (1) fraught interactions between patients and healthcare providers; (2) stigma-driven regulation of MOUD creating a culture of fear and defensive medicine; (3) a punitive culture in clinics and opioid treatment programs offering MOUD; and (4) the internalization of the abstinence narrative contributing to premature termination of treatment.ConclusionsOur analysis highlights how interdependent and non-linear feedback processes diminish or counteract the effectiveness and sustainability of MOUD policy interventions. Due to system memory and cultural resistance to change, even rolling back reactionary policies may do little to curb established behavioral patterns. In addition, conflicting and competing strategies among various actors within the system contribute to goal misalignment and a lack of standardization of care.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Teaching residents to prescribe buprenorphine for opioid use disorder: Insights from a community-based residency program
    Cavitt, Layla
    St Louis, Joshua
    Barr, Wendy B.
    Dono, Ryan
    Weida, Nicholas
    Sorcinelli, Mia
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 132
  • [32] Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers
    Pivovarova, Ekaterina
    Taxman, Faye S.
    Boland, Alexandra K.
    Smelson, David A.
    Lemon, Stephenie C.
    Friedmann, Peter D.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 147
  • [33] Use of Medications for Opioid Use Disorder and Child Welfare Outcomes
    Muhar, Alexandra
    McNeer, Elizabeth
    Presley, Lauren D.
    Morad, Anna
    Loch, Sarah F.
    Dupont, William D.
    Patrick, Stephen W.
    JAMA HEALTH FORUM, 2024, 5 (07): : e241768
  • [34] Impact of electronic prescribing on medication use and cost in community-based practices
    Fischer, M. A.
    Ferris, T. G.
    Vogeli, C.
    Stedman, M.
    Brookhart, M. A.
    Weissman, J. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 39 - 40
  • [35] Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis
    Muthulingam, Dharushana
    Hassett, Thomas C.
    Madden, Lynn M.
    Bromberg, Daniel J.
    Fraenkel, Liana
    Altice, Frederick L.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 154
  • [36] Medications for opioid use disorder: bridging the gap in care
    Volkow, Nora D.
    LANCET, 2018, 391 (10118): : 285 - 287
  • [37] Availability of Medications for Opioid Use Disorder in US Jails
    Sufrin, Carolyn
    Kramer, Camille
    Terplan, Mishka
    Fiscella, Kevin
    Olson, Sarah
    Voegtline, Kristin
    Latkin, Carl
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (06) : 1573 - 1575
  • [38] DEVELOPING MEDICATIONS FOR OPIOID USE DISORDER IN THE HUMAN LABORATORY
    Comer, S. D.
    Jones, J. D.
    Metz, V.
    Mogali, S.
    Manubay, J. M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 328A - 328A
  • [39] Prescribers’ satisfaction with delivering medications for opioid use disorder
    Hannah K. Knudsen
    Randy Brown
    Nora Jacobson
    Julie Horst
    Jee-Seon Kim
    Hanna Kim
    Lynn M. Madden
    Eric Haram
    Todd Molfenter
    Substance Abuse Treatment, Prevention, and Policy, 16
  • [40] Racial Inequality in Receipt of Medications for Opioid Use Disorder
    Barnett, Michael L. L.
    Meara, Ellen
    Lewinson, Terri
    Hardy, Brianna
    Chyn, Deanna
    Onsando, Moraa
    Huskamp, Haiden A. A.
    Mehrotra, Ateev
    Morden, Nancy E. E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (19): : 1779 - 1789